Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer

Multiple Cancer Types

The study will evaluate the clinical activity of nivolumab in combination with 3 separate investigational agents, glesatinib, sitravatinib, or mocetinostat.
Lung, Non Small Cell
II
Horn, Leora
NCT02954991
VICCTHO16139

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: